Rankings
▼
Calendar
ZBIO Q4 2024 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena
ZBIO
Zenas BioPharma, Inc.
$1B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
$5M
100.0% margin
Operating Income
-$56M
-1112.5% margin
Net Income
-$53M
-1052.1% margin
EPS (Diluted)
$-1.26
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$39M
Free Cash Flow
-$39M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$370M
Total Liabilities
$58M
Stockholders' Equity
$312M
Cash & Equivalents
$320M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$0
—
Gross Profit
$5M
-$20M
+124.5%
Operating Income
-$56M
-$25M
-124.5%
Net Income
-$53M
-$25M
-114.0%
← FY 2024
All Quarters
Q1 2025 →